Retraction
Total flavonoids suppress lung cancer growth via the COX‑2‑mediated Wnt/β‑catenin signaling pathway
Paper Information
Record ID:
51264
Author(s):
Journal:
Publication Date:
January 09, 2020
Retraction Date:
January 08, 2024
(1.9 year years ago)
Subjects:
Institutions:
- Department of Respiratory Medicine, Mudanjiang Medical University Affiliated Hongqi Hospital, Mudanjiang, Heilongjiang 157000, P.R. China
- Community Health Service Center, Mudanjiang Medical University Affiliated Hongqi Hospital, Mudanjiang, Heilongjiang 157000, P.R. China
- Department of Respiratory Medicine, Kangan Hospital, Mudanjiang, Heilongjiang 157000, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/ol.2024.14212Additional Notes:
see also: https://pubpeer.com/publications/2D03F4B9DB76044DAAE220DE77AAF1
Citations (12)
12
Total Citations2
Post-Retraction(16.7%)
10
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
475
Days since retraction (latest)
The role of Wnt/β-catenin signaling in lung cancer progression and therapy: a comprehensive review
Fares E.M. Ali, Khalid S.A. Badran, Mostafa S. Abd El‐Maksoud et al. (6 authors)
Medical Oncology
Published: Apr 2025
475 days after retraction
Regulation of Osteosarcoma Cell Proliferation, Migration, and Invasion by miR-143 and miR-199a Through COX-2 Targeting
Huang Bixin, Zheng Yuling, Ying Mai et al. (5 authors)
Dose-Response
Open Access
Published: Apr 2024
1 citation
1 citation
84 days after retraction
Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
Xuetong Shen, Chundi Gao, Huayao Li et al. (9 authors)
Frontiers in Pharmacology
Open Access
Published: Sep 2023
9 citations
9 citations
102 days before retraction
Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
Maliheh Entezari, Mahshid Deldar Abad Paskeh, Sima Orouei et al. (14 authors)
Current Cancer Drug Targets
Published: Apr 2023
4 citations
4 citations
265 days before retraction
Anticancer activities of Brachydin C in human prostate tumor cells (DU145) grown in 2D and 3D models: Stimulation of cell death and downregulation of metalloproteinases in spheroids
Larissa Cristina Bastos de Oliveira, Diego Luís Ribeiro, Lidiane do Nascimento Rodrigues et al. (6 authors)
Chemical Biology & Drug Design
Published: Jul 2022
7 citations
7 citations
556 days before retraction
Discussion on the Structural Modification and Anti-tumor Activity of Flavonoids
Zhugui Zhou, Dong‐Dong Li, Ying Chen et al. (5 authors)
Current Topics in Medicinal Chemistry
Published: Mar 2022
20 citations
20 citations
678 days before retraction
Nutraceuticals in Cancer Therapy
Shaimaa Fayez, Iriny M. Ayoub, Nada M. Mostafa et al. (6 authors)
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
Published: Jan 2022
737 days before retraction
Nutraceuticals in Cancer Therapy
Shaimaa Fayez, Iriny M. Ayoub, Nada M. Mostafa et al. (6 authors)
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
Published: Jan 2022
3 citations
3 citations
737 days before retraction
Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy
Devesh Tewari, Sweta Bawari, Shikha Sharma et al. (5 authors)
Pharmacology & Therapeutics
Published: Apr 2021
63 citations
63 citations
986 days before retraction
Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics
Shraddha Parate, Vikas Kumar, Jong Chan Hong et al. (4 authors)
Molecules
Open Access
Published: Apr 2021
8 citations
8 citations
1006 days before retraction
Interplay between cyclooxygenase‑2 and microRNAs in cancer (Review)
Zexiong Gong, Weiguo Huang, Baiyun Wang et al. (7 authors)
Molecular Medicine Reports
Open Access
Published: Mar 2021
13 citations
13 citations
1033 days before retraction
Trifolium Flavonoids Overcome Gefitinib Resistance of Non-Small-Cell Lung Cancer Cell by Suppressing ERK and STAT3 Signaling Pathways
Zhiqiang Wu, Bin Xu, Zhiyi Yu et al. (8 authors)
BioMed Research International
Open Access
Published: Oct 2020
12 citations
12 citations
1173 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025